Cargando…

Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan

BACKGROUND: The emergence of extensively drug-resistant (XDR) typhoid in Pakistan has endangered the treatment options available to manage this infection. Third generation cephalosporin were the empiric choice to treat typhoid fever in Pakistan, but acquisition of ESBLs have knocked them out of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabeen, Kokab, Saleem, Sidrah, Jahan, Shah, Nizamudin, Summiya, Arshad, Faiqa, Huma, Zill-e, Raza, Syed Mohsin, Mehmood, Maria, Roman, Muhammad, Haq, Faiz Ul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187657/
https://www.ncbi.nlm.nih.gov/pubmed/37201126
http://dx.doi.org/10.2147/IDR.S406253
_version_ 1785042777050972160
author Jabeen, Kokab
Saleem, Sidrah
Jahan, Shah
Nizamudin, Summiya
Arshad, Faiqa
Huma, Zill-e
Raza, Syed Mohsin
Mehmood, Maria
Roman, Muhammad
Haq, Faiz Ul
author_facet Jabeen, Kokab
Saleem, Sidrah
Jahan, Shah
Nizamudin, Summiya
Arshad, Faiqa
Huma, Zill-e
Raza, Syed Mohsin
Mehmood, Maria
Roman, Muhammad
Haq, Faiz Ul
author_sort Jabeen, Kokab
collection PubMed
description BACKGROUND: The emergence of extensively drug-resistant (XDR) typhoid in Pakistan has endangered the treatment options available to manage this infection. Third generation cephalosporin were the empiric choice to treat typhoid fever in Pakistan, but acquisition of ESBLs have knocked them out of the arsenal. The current empiric choice is azithromycin which is vulnerable to resistance too. This study aimed to assess the burden of XDR typhoid and the frequency of resistance determinants in blood culture samples collected from different hospitals in Lahore, Pakistan. METHODS: A total of 835 blood cultures were collected from different tertiary care hospitals in Lahore during January 2019 to December 2021. Among 835 blood cultures, 389 Salmonella Typhi were identified, and 150 were XDR S. Typhi (resistant to all recommended antibiotics). Antibiotics resistance genes of the first-line drugs (bla(TEM-1), catA1, sul1, and dhfR7) and second line drugs (gyrB, gyrA, qnrS, ParC and ParE) were investigated among XDR S. Typhi. There were different CTX-M genes isolated using the specific primers, bla(CTX-M-U), bla(CTX-M-1,) bla(CTX-M-15,) bla(CTX-M-2,) bla(CTX-M-8) and bla(CTX-M-9). RESULTS: Antibiotic resistant genes of the first-line drugs were isolated with different frequency, bla(TEM-1) (72.6%), catA1 (86.6%), sul1 (70%), and dhfR7 (56%). Antibiotics resistance genes of second-line drugs were isolated as: gyrB (60%), gyrA (49.3%), qnrS (32.6%), parC (44%) and parE (28%). Among CTX-M genes, bla(CTX-M-U) (63.3%) was the most frequent followed by bla(CTX-M-15) (39.3%) and bla(CTX-M-1) (26%). CONCLUSION: Our study concluded that XDR isolates circulating in Pakistan have acquired first-line and second-line antibiotic resistant genes quite successfully along with CTX-M genes (ESBLs) rendering them resistant to the third generation cephalosporins as well. Emergence of azithromycin resistance in XDR S. Typhi which is currently used as an empiric treatment option is worrisome and needs to be monitored carefully in endemic countries like Pakistan.
format Online
Article
Text
id pubmed-10187657
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-101876572023-05-17 Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan Jabeen, Kokab Saleem, Sidrah Jahan, Shah Nizamudin, Summiya Arshad, Faiqa Huma, Zill-e Raza, Syed Mohsin Mehmood, Maria Roman, Muhammad Haq, Faiz Ul Infect Drug Resist Original Research BACKGROUND: The emergence of extensively drug-resistant (XDR) typhoid in Pakistan has endangered the treatment options available to manage this infection. Third generation cephalosporin were the empiric choice to treat typhoid fever in Pakistan, but acquisition of ESBLs have knocked them out of the arsenal. The current empiric choice is azithromycin which is vulnerable to resistance too. This study aimed to assess the burden of XDR typhoid and the frequency of resistance determinants in blood culture samples collected from different hospitals in Lahore, Pakistan. METHODS: A total of 835 blood cultures were collected from different tertiary care hospitals in Lahore during January 2019 to December 2021. Among 835 blood cultures, 389 Salmonella Typhi were identified, and 150 were XDR S. Typhi (resistant to all recommended antibiotics). Antibiotics resistance genes of the first-line drugs (bla(TEM-1), catA1, sul1, and dhfR7) and second line drugs (gyrB, gyrA, qnrS, ParC and ParE) were investigated among XDR S. Typhi. There were different CTX-M genes isolated using the specific primers, bla(CTX-M-U), bla(CTX-M-1,) bla(CTX-M-15,) bla(CTX-M-2,) bla(CTX-M-8) and bla(CTX-M-9). RESULTS: Antibiotic resistant genes of the first-line drugs were isolated with different frequency, bla(TEM-1) (72.6%), catA1 (86.6%), sul1 (70%), and dhfR7 (56%). Antibiotics resistance genes of second-line drugs were isolated as: gyrB (60%), gyrA (49.3%), qnrS (32.6%), parC (44%) and parE (28%). Among CTX-M genes, bla(CTX-M-U) (63.3%) was the most frequent followed by bla(CTX-M-15) (39.3%) and bla(CTX-M-1) (26%). CONCLUSION: Our study concluded that XDR isolates circulating in Pakistan have acquired first-line and second-line antibiotic resistant genes quite successfully along with CTX-M genes (ESBLs) rendering them resistant to the third generation cephalosporins as well. Emergence of azithromycin resistance in XDR S. Typhi which is currently used as an empiric treatment option is worrisome and needs to be monitored carefully in endemic countries like Pakistan. Dove 2023-05-12 /pmc/articles/PMC10187657/ /pubmed/37201126 http://dx.doi.org/10.2147/IDR.S406253 Text en © 2023 Jabeen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jabeen, Kokab
Saleem, Sidrah
Jahan, Shah
Nizamudin, Summiya
Arshad, Faiqa
Huma, Zill-e
Raza, Syed Mohsin
Mehmood, Maria
Roman, Muhammad
Haq, Faiz Ul
Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan
title Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan
title_full Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan
title_fullStr Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan
title_full_unstemmed Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan
title_short Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan
title_sort molecular characterization of extensively drug resistant salmonella enterica serovar typhi clinical isolates from lahore, pakistan
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187657/
https://www.ncbi.nlm.nih.gov/pubmed/37201126
http://dx.doi.org/10.2147/IDR.S406253
work_keys_str_mv AT jabeenkokab molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan
AT saleemsidrah molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan
AT jahanshah molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan
AT nizamudinsummiya molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan
AT arshadfaiqa molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan
AT humazille molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan
AT razasyedmohsin molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan
AT mehmoodmaria molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan
AT romanmuhammad molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan
AT haqfaizul molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan